BlackRock Inc. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$7,062,000
-13.8%
303,888
-41.0%
0.00%
Q1 2018$8,194,000
-63.7%
514,666
-52.6%
0.00%
-100.0%
Q4 2017$22,559,000
-26.9%
1,085,500
-49.6%
0.00%0.0%
Q3 2017$30,856,000
+94.0%
2,153,506
+134.2%
0.00%0.0%
Q2 2017$15,904,000
+211.4%
919,335
+98.6%
0.00%
Q1 2017$5,107,000
+986.6%
462,930
+1328.8%
0.00%
-100.0%
Q4 2016$470,000
-40.9%
32,4000.0%0.00%0.0%
Q3 2016$795,000
+21.7%
32,4000.0%0.00%0.0%
Q2 2016$653,000
-37.8%
32,400
-18.8%
0.00%0.0%
Q1 2016$1,049,000
+3.1%
39,900
+299.0%
0.00%0.0%
Q4 2015$1,017,000
-95.2%
10,000
-91.6%
0.00%
-97.0%
Q3 2015$21,142,000
-35.1%
118,527
-19.1%
0.03%
-31.2%
Q2 2015$32,563,000
-20.7%
146,582
-29.1%
0.05%
-15.8%
Q1 2015$41,048,000
+4.4%
206,668
-24.8%
0.06%
+1.8%
Q4 2014$39,331,000
+23.2%
274,834
+13.0%
0.06%
+19.1%
Q3 2014$31,914,000
+25.2%
243,245
+20.3%
0.05%
+23.7%
Q2 2014$25,493,000
-5.7%
202,133
-1.5%
0.04%
-13.6%
Q1 2014$27,046,000
+14.6%
205,159
+2.0%
0.04%
+12.8%
Q4 2013$23,603,000
+141.6%
201,044
+114.7%
0.04%
+116.7%
Q3 2013$9,769,000
-2.3%
93,628
-19.4%
0.02%
-10.0%
Q2 2013$9,999,000116,1620.02%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2015
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders